
Revio Therapeutics LLP
About Revio Therapeutics LLP
Data last updated:
Revio Therapeutics LLP is a limited liability partnership (LLP) based in Hyderabad, Telangana, India. It operates in the general infrastructure services segment of the infrastructure and utilities sector. It was incorporated on 14 October 2020 and has been in existence for over 6 years.
The LLP is registered with the Registrar of Companies (ROC), Hyderabad, under LLPIN AAU-2475.
The LLP has a total obligation of contribution of ₹1.01 Cr. It is led by designated partners including Jyothi Raju Chintalapati and Akila Chandrashekar Raju.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Ilabs Centre Building No. III No. 18 Software Units Layout Madhapur, Hyderabad, Telangana, India – 500081.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressIlabs Centre Building No. III No. 18 Software Units Layout Madhapur, Hyderabad, Telangana, India – 500081
- IndustryInfrastructure and Utilities, General Infrastructure Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Revio Therapeutics LLP FY 2025 filings available
Financial Statement Summary of Revio Therapeutics LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Revio Therapeutics LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Revio Therapeutics are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Revio Therapeutics LLP
Revio Therapeutics has 3 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jyothi Raju Chintalapati | Designated Partner | 14 Oct 2020 | 5 Years 11 Months | Current |
| Akila Chandrashekar Raju | Designated Partner | 14 Oct 2020 | 5 Years 11 Months | Current |
| Duddukuri Venkata Dhanumjaya Rao | Designated Partner | 01 May 2025 | 1 Years 5 Months | Current |
Charges & Borrowings of Revio Therapeutics LLP
Revio Therapeutics LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Revio Therapeutics LLP
Employment history and EPFO contributions of people linked to Revio Therapeutics.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Revio Therapeutics LLP
Revio Therapeutics LLP has 3 designated partner changes on record since 2020: 3 appointments. The latest: Duddukuri Venkata Dhanumjaya Rao was appointed as Designated Partner on 01 May 2025.
Credit Ratings, Litigation & Regulatory Alerts for Revio Therapeutics LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Revio Therapeutics LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Revio Therapeutics LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Revio Therapeutics LLP
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Revio Therapeutics LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Revio Therapeutics LLP
Revio Therapeutics is an active limited liability partnership based in Hyderabad, Telangana, India. The LLP works in general infrastructure services, within the infrastructure and utilities industry. It was incorporated on 14 October 2020 (6+ years old) and is registered under LLPIN AAU-2475.
Revio Therapeutics has 3 current designated partners:
- Jyothi Raju Chintalapati - Designated Partner
- Akila Chandrashekar Raju - Designated Partner
- Duddukuri Venkata Dhanumjaya Rao - Designated Partner
The LLPIN (Limited Liability Partnership Identification Number) of Revio Therapeutics is AAU-2475. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Revio Therapeutics was incorporated on 14 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
Duddukuri Venkata Dhanumjaya Rao was appointed as Designated Partner on 01 May 2025. Akila Chandrashekar Raju was appointed as Designated Partner on 14 Oct 2020. Jyothi Raju Chintalapati was appointed as Designated Partner on 14 Oct 2020.
The registered office of Revio Therapeutics is at Ilabs Centre Building No. III No. 18 Software Units Layout Madhapur, Hyderabad, Telangana, India – 500081.
The total obligation of contribution is ₹1.01 Cr.
Revio Therapeutics operates in the infrastructure and utilities industry, in the general infrastructure services segment.
Revio Therapeutics can be reached at its registered office: Ilabs Centre Building No. III No. 18 Software Units Layout Madhapur, Hyderabad, Telangana, India – 500081.
Revio Therapeutics is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.